Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
暂无分享,去创建一个
George Coukos | Xavier Alvarez | Leann Myers | Weiping Zou | Lin Zhang | G. Coukos | T. Curiel | Lieping Chen | A. Lackner | M. Burow | B. Daniel | W. Zou | L. Myers | K. Knutson | M. Disis | Ilona Kryczek | Lieping Chen | Yun Zhu | Lin Zhang | Mary L Disis | Andrew Lackner | Shuang Wei | J. Conejo-Garcia | L. Zou | X. Alvarez | P. Cheng | P. Mottram | Melina Evdemon-Hogan | Alan Gordon | Ilona Kryczek | Linhua Zou | Shuang Wei | Peter Mottram | Pui Cheng | Jose R Conejo-Garcia | Keith L Knutson | Tyler J Curiel | Melina Evdemon-Hogan | Matthew Burow | Yun Zhu | Ben Daniel | Alan Gordon | Xavier Alvarez
[1] M. Markman. Optimizing primary chemotherapy in ovarian cancer. , 2003, Hematology/oncology clinics of North America.
[2] J. Cyster,et al. Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. , 1999, Science.
[3] T. Curiel,et al. Macrophage-Derived Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by β-Chemokines Rather Than IL-121 , 2000, The Journal of Immunology.
[4] Leonard C. Harrison,et al. Regulatory lymphocytes: Antigen-induced regulatory T cells in autoimmunity , 2003, Nature Reviews Immunology.
[5] M. Roncarolo,et al. Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function , 2001, The Journal of experimental medicine.
[6] V. Cerundolo,et al. Mature Dendritic Cells Prime Functionally Superior Melan-A-Specific CD8+ Lymphocytes as Compared with Nonprofessional APC1 , 2001, The Journal of Immunology.
[7] Meng-tse Wu,et al. Cutting Edge: CCR4 Mediates Antigen-Primed T Cell Binding to Activated Dendritic Cells , 2001, The Journal of Immunology.
[8] T. Curiel,et al. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity , 2003, Nature Medicine.
[9] R. Lechler,et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. , 2001, Blood.
[10] D. Pardoll,et al. Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.
[11] T. Nomura,et al. Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .
[12] A. Iellem,et al. Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells , 2001, The Journal of experimental medicine.
[13] H. Waldmann,et al. Regulatory T cells in transplantation tolerance. , 2005, Current topics in microbiology and immunology.
[14] N. Restifo,et al. Natural selection of tumor variants in the generation of “tumor escape” phenotypes , 2002, Nature Immunology.
[15] G. Schuler,et al. Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood , 2001, The Journal of experimental medicine.
[16] G. Coukos,et al. Regulatory CD 4 1 CD 25 1 T Cells in Tumors from Patients with Early-Stage Non-Small Cell Lung Cancer and Late-Stage Ovarian Cancer 1 , 2001 .
[17] Mario Roederer,et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients , 1999, Nature Medicine.
[18] K. Wood,et al. Regulatory lymphocytes: Regulatory T cells in transplantation tolerance , 2003, Nature Reviews Immunology.
[19] Sayuri Yamazaki,et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance , 2001, Immunological reviews.
[20] Ethan M. Shevach,et al. CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.
[21] E. Shevach. Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.
[22] K. Wood,et al. Cutting Edge: CD4+CD25+ Alloantigen-Specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-Mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy1 , 2002, The Journal of Immunology.
[23] G. Freeman,et al. CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. , 2003, Novartis Foundation symposium.
[24] Y. Rivière,et al. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. , 2001, Journal of immunological methods.
[25] Clare Baecher-Allan,et al. Inhibition of Human CD4+CD25+high Regulatory T Cell Function1 , 2002, The Journal of Immunology.
[26] R. Noelle,et al. Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade , 2001, The Journal of experimental medicine.
[27] Christopher Anderson,et al. More questions than answers , 1991, Nature.
[28] S. Riddell,et al. Prospects for adoptive T cell therapy. , 1997, Current opinion in immunology.
[29] G. Freeman,et al. CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.
[30] George Coukos,et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.
[31] C. June,et al. Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1 , 2002, The Journal of Immunology.
[32] B. Blazar,et al. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. , 2002, Blood.
[33] K. Knutson,et al. Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients. , 2001, The Journal of clinical investigation.
[34] F. Powrie,et al. CD4(+) regulatory T cells. , 2001, Current opinion in immunology.
[35] H. Schreiber,et al. Immunodominance and tumor escape. , 2002, Seminars in cancer biology.
[36] A. Harris,et al. A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response1 , 2000, The Journal of Immunology.
[37] E. Shevach,et al. Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells , 2001, The Journal of Immunology.
[38] T. Eberlein,et al. Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1 , 2002, The Journal of Immunology.
[39] G. Coukos,et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. , 2001, Cancer research.
[40] G. Ogg,et al. Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes , 1998, The Journal of experimental medicine.
[41] T. Tüting,et al. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. , 2001, Cancer research.
[42] J. Bach. Regulatory lymphocytes: Regulatory T cells under scrutiny , 2003, Nature Reviews Immunology.
[43] J. Shimizu,et al. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. , 1999, Journal of immunology.
[44] T. Curiel,et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells , 2001, Nature Medicine.
[45] I. Bièche,et al. Quantification of estrogen receptor α and β expression in sporadic breast cancer , 2001, Oncogene.
[46] M. Maio,et al. Melanoma immunotherapy: new dreams or solid hopes? , 1996, Immunology today.
[47] J. Kirkwood,et al. New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines , 1996, Melanoma research.
[48] F. Ramsdell,et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.
[49] P. Galanaud,et al. Quantification of cytokine gene expression by competitive PCR using a colorimetric assay. , 1995, European cytokine network.
[50] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[51] D. Keskin,et al. Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase , 2002, Science.
[52] A. Rudensky,et al. Foxp 3 programs the development and function of CD 4 + CD 25 + regulatory T cells , 2003 .